Related references
Note: Only part of the references are listed.Ultra-Processed Food Consumption and Increased Risk of Metabolic Syndrome in Adults: The ELSA-Brasil
Scheine Leite Canhada et al.
DIABETES CARE (2023)
Ketogenic diet protects myelin and axons in diffuse axonal injury
Jiao Mu et al.
NUTRITIONAL NEUROSCIENCE (2022)
Co-delivery of EGCG and lycopene via a pickering double emulsion induced synergistic hypolipidemic effect
Qun Wang et al.
FOOD & FUNCTION (2022)
The role of cholesterol metabolism in multiple sclerosis: From molecular pathophysiology to radiological and clinical disease activity
Balazs Lorincz et al.
AUTOIMMUNITY REVIEWS (2022)
The Role of Ketogenic Diet in the Treatment of Neurological Diseases
Damian Dynka et al.
NUTRIENTS (2022)
Effect of β-hydroxybutyrate on behavioral alterations, molecular and morphological changes in CNS of multiple sclerosis mouse model
Wei Sun et al.
FRONTIERS IN AGING NEUROSCIENCE (2022)
Exogenous Antioxidants in Remyelination and Skeletal Muscle Recovery
Ricardo Julian Cabezas Perez et al.
BIOMEDICINES (2022)
Vascular dysfunction and dyslipidemia in multiple sclerosis: are they correlated with disease duration and disability status?
Hesham Boshra et al.
EGYPTIAN HEART JOURNAL (2022)
Epigallocatechin gallate decreases plasma triglyceride, blood pressure, and serum kisspeptin in obese human subjects
Saimai Chatree et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2021)
Neutrophil-to-lymphocyte ratio and CRP as biomarkers in multiple sclerosis: A systematic review
Anna Olsson et al.
ACTA NEUROLOGICA SCANDINAVICA (2021)
Dietary risk factors of primary progressive multiple sclerosis: A population-based case-control study
Nasim Rezaeimanesh et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels
Aparna Sajja et al.
JAMA NETWORK OPEN (2021)
The Potential Health Benefits of the Ketogenic Diet: A Narrative Review
Kathryn Dowis et al.
NUTRIENTS (2021)
High Consumption of Ultra-Processed Food is Associated with Incident Dyslipidemia: A Prospective Study of Older Adults
Carolina Donat-Vargas et al.
JOURNAL OF NUTRITION (2021)
Interactions of Lipids, Lipoproteins, and Apolipoproteins with the Blood-Brain Barrier
Elizabeth M. Rhea et al.
PHARMACEUTICAL RESEARCH (2021)
Beneficial Effects of Exogenous Ketogenic Supplements on Aging Processes and Age-Related Neurodegenerative Diseases
Zsolt Kovacs et al.
NUTRIENTS (2021)
The Impact of Coconut Oil and Epigallocatechin Gallate on the Levels of IL-6, Anxiety and Disability in Multiple Sclerosis Patients
Jose Luis Platero et al.
NUTRIENTS (2020)
The Relation between Eating Habits and Abdominal Fat, Anthropometry, PON1 and IL-6 Levels in Patients with Multiple Sclerosis
Eraci Drehmer et al.
NUTRIENTS (2020)
Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation?
Zofia Radikova et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Low high-density lipoprotein cholesterol and high triglycerides lipid profile in neuromyelitis optica spectrum disorder: Associations with disease activity and disability
Eun Bin Cho et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-β Distribution between Brain and Plasma
Suresh K. Swaminathan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Lipid profile: causal relationship on cognitive performance in multiple sclerosis?
Ana Laura Hernandez-Ledesma et al.
MOLECULAR BIOLOGY REPORTS (2020)
Possible Reduction of Cardiac Risk after Supplementation with Epigallocatechin Gallate and Increase of Ketone Bodies in the Blood in Patients with Multiple Sclerosis. A Pilot Study
Maria Benlloch et al.
NUTRIENTS (2020)
Epigallocatechin Gallate Modulates Muscle Homeostasis in Type 2 Diabetes and Obesity by Targeting Energetic and Redox Pathways: A Narrative Review
Ester Casanova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Apolipoprotein A-I Crosses the Blood-Brain Barrier through Clathrin-Independent and Cholesterol-Mediated Endocytosis
Andrew L. Zhou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Anticatabolic Effects of Ketone Bodies in Skeletal Muscle
Andrew P. Koutnik et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
Function of Green Tea Catechins in the Brain: Epigallocatechin Gallate and its Metabolites
Monira Pervin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study
Kelly Fellows Maxwell et al.
PLOS ONE (2019)
Triglycerides cross the blood-brain barrier and induce central leptin and insulin receptor resistance
W. A. Banks et al.
INTERNATIONAL JOURNAL OF OBESITY (2018)
Inflammation as a Possible Link Between Dyslipidemia and Alzheimer's Disease
Bruno Cabral de Lima Oliveira et al.
NEUROSCIENCE (2018)
Lipoprotein markers associated with disability from multiple sclerosis
A. R. Gafson et al.
SCIENTIFIC REPORTS (2018)
EGCG Reduces Obesity and White Adipose Tissue Gain Partly Through AMPK Activation in Mice
Fang Li et al.
FRONTIERS IN PHARMACOLOGY (2018)
Blood-Brain Barrier Permeability of Green Tea Catechin Metabolites and their Neuritogenic Activity in Human Neuroblastoma SH-SY5Y Cells
Keiko Unno et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2017)
Oral β-hydroxybutyrate increases ketonemia, decreases visceral adipocyte volume and improves serum lipid profile in Wistar rats
Rennan de Oliveira Caminhotto et al.
NUTRITION & METABOLISM (2017)
Effects of Epigallocatechin-3-Gallate on Autophagic Lipolysis in Adipocytes
Sang-Nam Kim et al.
NUTRIENTS (2017)
The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer's disease: an overview of pre-clinical studies and translational perspectives in clinical practice
Marco Cascella et al.
INFECTIOUS AGENTS AND CANCER (2017)
SR-BI Mediated Transcytosis of HDL in Brain Microvascular Endothelial Cells Is Independent of Caveolin, Clathrin, and PDZK1
Karen Y. Fung et al.
FRONTIERS IN PHYSIOLOGY (2017)
Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis
Yaqing Shu et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Efficacy and Tolerability of Phytomedicines in Multiple Sclerosis Patients: A Review
Mohammad Hosein Farzaei et al.
CNS DRUGS (2017)
Comorbidity and metabolic syndrome in patients with multiple sclerosis from Asturias and Catalonia, Spain
Antoni Sicras-Mainar et al.
BMC NEUROLOGY (2017)
A randomized, placebo-controlled, double-blind study on the effects of (-)- epicatechin on the triglyceride/HDLc ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects
Gabriela Gutierrez-Salmean et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis
Bozena Adamczyk et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Overnutrition Determines LPS Regulation of Mycotoxin Induced Neurotoxicity in Neurodegenerative Diseases
Ian James Martins
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients
Kelly Fellows et al.
JOURNAL OF LIPID RESEARCH (2015)
Preventive role of green tea catechins from obesity and related disorders especially hypercholesterolemia and hyperglycemia
Rabia Shabir Ahmad et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Epigallocatechin-3-Gallate, a Promising Molecule for Parkinson's Disease?
Justine Renaud et al.
REJUVENATION RESEARCH (2015)
Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome
Samuel Legeay et al.
NUTRIENTS (2015)
Importance of Apolipoprotein A-I in Multiple Sclerosis
Lidia A. Gardner et al.
FRONTIERS IN PHARMACOLOGY (2015)
A role for Apolipoprotein A-I in the pathogenesis of multiple sclerosis
Lindsay Meyers et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Epigallocatechin gallate (EGCG) attenuates infrasound-induced neuronal impairment by inhibiting microglia-mediated inflammation
Jing Cai et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
An adverse lipid profile is associated with disability and progression in disability, in people with MS
Prudence Tettey et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Resveratrol and EGCG bind directly and distinctively to miR-33a and miR-122 and modulate divergently their levels in hepatic cells
Laura Baselga-Escudero et al.
NUCLEIC ACIDS RESEARCH (2014)
Novel immunoregulatory properties of EGCG on reducing inflammation in EAE
Quanye Sun et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2013)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review
Inez Wens et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Involvement of Oxidative Stress in Occurrence of Relapses in Multiple Sclerosis: The Spectrum of Oxidatively Modified Serum Proteins Detected by Proteomics and Redox Proteomics Analysis
Ada Fiorini et al.
PLOS ONE (2013)
Emerging role of high density lipoproteins as a player in the immune system
Giuseppe Danilo Norata et al.
ATHEROSCLEROSIS (2012)
Epigallocatechin gallate changes mRNA expression level of genes involved in cholesterol metabolism in hepatocytes
Tsuyoshi Goto et al.
BRITISH JOURNAL OF NUTRITION (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
EUROPEAN HEART JOURNAL (2012)
Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis
Bianca Weinstock-Guttman et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Cholesterol involvement in the pathogenesis of neurodegenerative diseases
Jun-Ping Liu et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2010)
Leukocyte activation by triglyceride-rich lipoproteins
Arash Alipour et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Niaspan treatment improves neurological functional recovery in experimental autoimmune encephalomyelitis mice
Jing Zhang et al.
NEUROBIOLOGY OF DISEASE (2008)
Beneficial effects of ketogenic diet in obese diabetic subjects
Hussein M. Dashti et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
Gait and balance impairment in early multiple sclerosis in the absence of clinical disability
C. L. Martin et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
High sensitivity measurement of CRP and disease progression in multiple sclerosis
M Soilu-Hänninen et al.
NEUROLOGY (2005)
Uptake and transport of high-density lipoprotein (HDL) and HDL-associated α-tocopherol by an in vitro blood-brain barrier model
Z Balazs et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Cross-bridge mechanisms of muscle weakness in multiple sclerosis
DJP Garner et al.
MUSCLE & NERVE (2003)
A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men
MJ Sharman et al.
JOURNAL OF NUTRITION (2002)
Share Paper
